LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 23 of 497
Next
>>
>
551 to 575 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	Neratinib	0.12	uM	LJP5	2	A17	72	hr	1657	4442	5505	0.8068	0.7236
BT-20	Neratinib	0.12	uM	LJP5	3	A17	72	hr	1657	4415	5505	0.8019	0.7166
BT-20	Nilotinib	0.12	uM	LJP5	1	N17	72	hr	1657	5349	5505	0.9715	0.9593
BT-20	Nilotinib	0.12	uM	LJP5	2	N17	72	hr	1657	5368	5505	0.9750	0.9642
BT-20	Nilotinib	0.12	uM	LJP5	3	N17	72	hr	1657	5486	5505	0.9964	0.9949
BT-20	Nintedanib	0.12	uM	LJP6	1	H05	72	hr	1657	5702	5505	1.0357	1.0510
BT-20	Nintedanib	0.12	uM	LJP6	2	H05	72	hr	1657	5736	5505	1.0418	1.0599
BT-20	Nintedanib	0.12	uM	LJP6	3	H05	72	hr	1657	5767	5505	1.0475	1.0679
BT-20	NU7441	0.12	uM	LJP5	1	C11	72	hr	1657	6003	5505	1.0903	1.1292
BT-20	NU7441	0.12	uM	LJP5	2	C11	72	hr	1657	5579	5505	1.0133	1.0191
BT-20	NU7441	0.12	uM	LJP5	3	C11	72	hr	1657	6126	5505	1.1127	1.1612
BT-20	Dactolisib	0.12	uM	LJP5	1	M17	72	hr	1657	2358	5505	0.4283	0.1820
BT-20	Dactolisib	0.12	uM	LJP5	2	M17	72	hr	1657	2363	5505	0.4292	0.1833
BT-20	Dactolisib	0.12	uM	LJP5	3	M17	72	hr	1657	2317	5505	0.4208	0.1713
BT-20	NVP-TAE684	0.12	uM	LJP6	1	K17	72	hr	1657	3833	5505	0.6962	0.5653
BT-20	NVP-TAE684	0.12	uM	LJP6	2	K17	72	hr	1657	3721	5505	0.6759	0.5362
BT-20	NVP-TAE684	0.12	uM	LJP6	3	K17	72	hr	1657	3623	5505	0.6581	0.5107
BT-20	Palbociclib	0.12	uM	LJP6	1	E17	72	hr	1657	3423	5505	0.6217	0.4588
BT-20	Palbociclib	0.12	uM	LJP6	2	E17	72	hr	1657	3149	5505	0.5720	0.3876
BT-20	Palbociclib	0.12	uM	LJP6	3	E17	72	hr	1657	3689	5505	0.6700	0.5279
BT-20	PD0325901	0.12	uM	LJP5	1	C05	72	hr	1657	5215	5505	0.9472	0.9245
BT-20	PD0325901	0.12	uM	LJP5	2	C05	72	hr	1657	4871	5505	0.8847	0.8351
BT-20	PD0325901	0.12	uM	LJP5	3	C05	72	hr	1657	4963	5505	0.9014	0.8590
BT-20	PD0325901	0.12	uM	LJP6	1	E05	72	hr	1657	4692	5505	0.8522	0.7885
BT-20	PD0325901	0.12	uM	LJP6	2	E05	72	hr	1657	5077	5505	0.9221	0.8886

|<
<<
Previous
Page 23 of 497
Next
>>
>
551 to 575 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)